Julian Baumeister

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Julian Baumeister, Nicolas Chatain, Annika Hubrich et al. · Leukemia · 2019 · 114 citations

Hematological Malignancy, New Therapeutic Target, Hypoxia (Medicine) +8

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation

Julia Czech, Sabrina Cordua, Barbora Weinbergerová et al. · Leukemia · 2018 · 57 citations

Transcriptional Regulation, Increased Molecular Responses, Signal Transduction +13

Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis

Kim Ohl, Athanassios Fragoulis, Patricia Klemm et al. · Frontiers in Immunology · 2018 · 51 citations · Full text

Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha

Claudia Schubert, Manuel Allhoff, Stefan Tillmann et al. · Journal of Hematology & Oncology · 2019 · 29 citations · Full text

Engineering Mesoscopic 3D Tumor Models with a Self‐Organizing Vascularized Matrix

Federica De Lorenzi, Nadja Hansen, Benjamin Theek et al. · Advanced Materials · 2023 · 24 citations · Full text